Displaying 21 to 40 of 64 investments
Country Date Notes
Cognetix
Biopharmaceutical company that developed peptide therapeutics for the treatment of epilepsy, pain and anesthesia.
United States N/A
CoLucid Pharmaceuticals
Biopharmaceutical company developing therapeutics to treat neurological dysfunctions.
United States 1 Jan 2006 Series A
CoLucid Pharmaceuticals
Biopharmaceutical company developing therapeutics to treat neurological dysfunctions.
United States 1 Jan 2008 Series B
CoLucid Pharmaceuticals
Biopharmaceutical company developing therapeutics to treat neurological dysfunctions.
United States 1 Aug 2011 N/A
Dynogen Pharmaceuticals Inc
Drug company focused on gastrointestinal and genitourinary disorders.
United States N/A
EBM Solutions
United States N/A
Elitra Phramaceuticals
Antimicrobial functional genomics company
United States N/A
Emerald BioAgriculture Corp
Bioagriculture company developing, manufacturing and marketing biological and biochemical agents.
United States N/A
Exelixis Inc
United States N/A
FlowCardia Inc
A medical device company commercializing products for the treatment of chronic total occlusions (CTOs) of coronary and peripheral arteries.
United States N/A
Gentis Inc
Developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine.
United States N/A
Horizon Quantum Computing Pte Ltd
Developer of a new generation of programming tools to simplify and expedite the process of developing software for quantum computers.
Singapore 31 Mar 2023 Series A
Initial investment. Round participant. Active
IlluminOss Medical Inc
A privately held medical device company dedicated to the development of minimally invasive orthopedic systems.
United States 1 Sep 2012 Series C
Active
LEAD Therapeutics
A chemistry-driven small-molecule drug discovery company
United States N/A
LipoScience Inc
Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy.
1 Aug 2003 Series E
Active
LipoScience Inc
Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy.
1 Aug 2006 Series F
Active
Liquidia Technologies Inc
United States N/A
Lumena Pharmaceuticals Inc
United States N/A
Active
Lumena Pharmaceuticals Inc
United States 8 May 2013 Series A
Active
Marina Biotech
United States N/A